These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2982210)

  • 1. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors.
    Vogelstein B; Fearon ER; Hamilton SR; Feinberg AP
    Science; 1985 Feb; 227(4687):642-5. PubMed ID: 2982210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clonal study of hematopoiesis using the M27 beta probe: aberrant band patterns caused by incomplete digestion of a methyl-sensitive enzyme in the the inactive X-chromosome.
    Jinnai I; Yoshida S; Toyoda A; Murohashi I; Bessho M; Hirashima K; Nagai K; Tomonaga M; Boyd Y
    Leukemia; 1993 Sep; 7(9):1432-6. PubMed ID: 8103812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal analysis using recombinant DNA probes from the X-chromosome.
    Vogelstein B; Fearon ER; Hamilton SR; Preisinger AC; Willard HF; Michelson AM; Riggs AD; Orkin SH
    Cancer Res; 1987 Sep; 47(18):4806-13. PubMed ID: 2887283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.
    Fey MF; Peter HJ; Hinds HL; Zimmermann A; Liechti-Gallati S; Gerber H; Studer H; Tobler A
    J Clin Invest; 1992 May; 89(5):1438-44. PubMed ID: 1349026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.
    Koufos A; Hansen MF; Lampkin BC; Workman ML; Copeland NG; Jenkins NA; Cavenee WK
    Nature; 1984 May 10-16; 309(5964):170-2. PubMed ID: 6325936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of clonality in acute nonlymphocytic leukemia by restriction fragment length polymorphism and methylation analysis.
    Yoffe G; Spitzer G; Boggs BA; McCredie KB; Stass SA; Chinault AC
    Leukemia; 1987 Mar; 1(3):226-30. PubMed ID: 2889856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential loss of maternal alleles in sporadic Wilms' tumour.
    Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single nucleotide polymorphism chip-based method for combined genetic and epigenetic profiling: validation in decitabine therapy and tumor/normal comparisons.
    Yuan E; Haghighi F; White S; Costa R; McMinn J; Chun K; Minden M; Tycko B
    Cancer Res; 2006 Apr; 66(7):3443-51. PubMed ID: 16585166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of human colorectal tumors.
    Fearon ER; Hamilton SR; Vogelstein B
    Science; 1987 Oct; 238(4824):193-7. PubMed ID: 2889267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal analysis of solitary follicular nodules in the thyroid.
    Hicks DG; LiVolsi VA; Neidich JA; Puck JM; Kant JA
    Am J Pathol; 1990 Sep; 137(3):553-62. PubMed ID: 1975986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene.
    Lee JS; Ro JS; Eisbruch A; Shtalrid M; Ferrell RE; Gutterman JU; Blick M
    Cancer Res; 1988 Jul; 48(14):4045-8. PubMed ID: 2898288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of human cancer.
    Knudson AG
    Annu Rev Genet; 1986; 20():231-51. PubMed ID: 2880556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism.
    Minden MD; Messner HA; Belch A
    J Clin Invest; 1985 Jan; 75(1):91-3. PubMed ID: 2981254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor-suppressor genes].
    Horikawa I; Oshimura M
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):153-9. PubMed ID: 1671547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chromosome abnormalities and tumor suppressor gene in childhood cancer].
    Hayashi Y
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2327-32. PubMed ID: 1979726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically nonfunctioning pituitary tumors are monoclonal in origin.
    Alexander JM; Biller BM; Bikkal H; Zervas NT; Arnold A; Klibanski A
    J Clin Invest; 1990 Jul; 86(1):336-40. PubMed ID: 1973174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes.
    Guertl B; Leuschner I; Harms D; Hoefler G
    Virchows Arch; 2006 Aug; 449(2):171-4. PubMed ID: 16715229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia.
    Hamdy MS; El-Haddad AM; Bahaa El-Din NM; Makhlouf MM; Abdel-Hamid SM
    J Investig Med; 2011 Oct; 59(7):1124-30. PubMed ID: 21725251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.